DRL's management has guided for double-digit growth in FY26, with margins expected to remain similar to FY25 levels. Here's ...

Our team has been researching these complications for over a decade. One major development was the addition of the drug ...

Abatacept is a disease-modifying antirheumatic drug (DMARD) used in the management of rheumatic conditions, such as ...

DENVER — New analyses of results from the first-line options for systemic juvenile idiopathic arthritis (sJIA) treatment (FROST) study revealed insights into long-term outcomes of treatment with ...